Publications:106
Jordi Ochando, PhD
About Me
Jordi Ochando, Ph.D. is an Assistant Professor of Oncological Sciences and Director of the Flow Cytometry CoRE at the Icahn School of Medicine at Mount Sinai. The Ochando laboratory investigates the origin, development, and immune function of macrophages in organ transplantation. His laboratory has recently discovered that trained immunity represents a previously unrecognized pathway that mediates allograft rejection. To prevent the detrimental effects of trained macrophages, the Ochando laboratory uses a novel revolutionary targeted therapeutic delivery approach in which drug-loaded nanobiologics that specifically target macrophages in vivo and induce long-term allograft acceptance. This research represents a compelling framework for developing novel targeted therapies that promote immunological tolerance.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Nephrology, ASSISTANT PROFESSOR | Oncological Sciences, ASSISTANT PROFESSOR | Immunology & Immunotherapy
Research Topics
Cancer, Dendritic Cells, Growth, Immunological Tolerance, Transplantation
Multi-Disciplinary Training Areas
Immunology [IMM]
Education
B.Sc., University of Alicante
Ph.D., De Montfort University
Publications
Selected Publications
- Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity. Inge Jonkman, Maaike M.E. Jacobs, Leonie S. Helder, Yutaka Negishi, Jordi Ochando, Joren C. Madsen, Musa M. Mhlanga, Abraham J.P. Teunissen, Leo A.B. Joosten, Mihai G. Netea, Luuk B. Hilbrands, Nils Rother, Raphaël Duivenvoorden. iScience
- Effect of PI3K-p110α Inhibitor Alpelisib in the Differentiation and Effector Functions of M-CSF and GM-CSF Macrophages. Cristina Villa-Gómez, Verónica Bermejo, Inmaculada Márquez-Leiva, Jana Baranda, Alejandro C. Briones, Isabel Cervera, Jordi Ochando, José María Rojo, Pilar Portolés. International Journal of Molecular Sciences
- Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice. Juan García Bernalt Diego, Javier Arranz-Herrero, Gabriel Laghlali, Eleanor Burgess, Seok Chan Park, Gagandeep Singh, Lauren A. Chang, Prajakta Warang, Moataz Noureddine, Jordi Ochando, Estanislao Nistal-Villan, Michael Schotsaert. Journal of Virology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ochando did not report having any of the following types of financial relationships with industry and other outside entities during 2025 and/or 2026: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.